AtaiBeckley (ATAI) Net Margin (2021 - 2026)
AtaiBeckley (ATAI) recorded quarterly Net Margin of 3121.8% in Q1 2026, down 83.66% quarter-over-quarter from 1699.74% in Q1 2025, and down 142206.0% on a YoY basis from N/an in Q1 2025.
AtaiBeckley (ATAI) Net Margin (2021 - 2026) Analysis & Trends
AtaiBeckley has disclosed Net Margin across 5 years of filings, most recently posting 8154.07% for Q3 2025.
- Net Margin for Q3 2025 came in at 8154.07%, up 5756093.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 5080.46% (up 3377241.0% YoY), and the FY2024 annual result was 48463.96%, down 3565377.0% from the prior year.
- Net Margin was 3121.8% for Q1 2026 at AtaiBeckley, down from 1699.74% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 1699.74% in Q1 2025 to a low of 3121.8% in Q1 2026.
- The 5-year median for Net Margin is 21266.7% (2022), against an average of 56261.37%.
- Across the five-year window, Net Margin jumped 19205101 bps in 2023 and tumbled 22302778 bps in 2024, its largest moves.
- AtaiBeckley's Net Margin stood at 22667.83% in 2021, then slumped by 423 bps to 118450.0% in 2022, then gained by 14 bps to 101622.22% in 2023, then slumped by 219 bps to 324650.0% in 2024, then soared by 97 bps to 8154.07% in 2025.
- The last three Net Margin figures came in at 8154.07% (Q3 2025), 3856.61% (Q2 2025), and 1699.74% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | -3,121.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,121.80% |
| Sep 30, 2025 | -8,154.07% |
| Jun 30, 2025 | -3,856.61% |
| Mar 31, 2025 | -1,699.74% |
| Mar 31, 2025 | -1,699.74% |
| Dec 31, 2024 | -324,650.00% |
| Sep 30, 2024 | -65,715.00% |
| Jun 30, 2024 | -20,993.41% |
| Dec 31, 2023 | -101,622.22% |
| Sep 30, 2023 | 50,855.17% |
| Jun 30, 2023 | -19,210.47% |
| Mar 31, 2023 | -89,554.05% |
| Dec 31, 2022 | -118,450.00% |
| Sep 30, 2022 | -141,195.83% |
| Jun 30, 2022 | -21,540.00% |
| Dec 31, 2021 | -22,667.83% |
| Sep 30, 2021 | -11,713.53% |
| Mar 31, 2021 | -14.37% |